Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|February 11, 2022
A Need for More Molecular Profiling in Brain MetastasesErica Shen, Amanda E D Van Swearingen, Meghan J Price, et al.
Cancers|November 11, 2022
Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation StudyDavid J Carpenter, Brahma Natarajan, Muzamil Arshad, et al.
Neuro-Oncology|May 21, 2024
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncologyRifaquat Rahman, Diana D Shi, Zachary J Reitman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2023
Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain MetastasesEugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
Neuro-Oncology|January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of TelomeresAlexandrea Brown, Laura M Strickland, Elise N Erman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.
The Lancet. Oncology|November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic reviewTarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
Nature Cancer|February 5, 2025
FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapyHaiwei Ni, Zachary J Reitman, Wei Zou, et al.
Oncotarget|April 18, 2013
Exomic sequencing of four rare central nervous system tumor typesChetan Bettegowda, Nishant Agrawal, Yuchen Jiao, et al.
Oncotarget|April 12, 2014
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomasPatrick J Killela, Christopher J Pirozzi, Patrick Healy, et al.
Pageof 8